NCT05270005

Brief Summary

Rationale: Approximately 15-20% of strokes originates from an atherosclerotic plaque rupture in the carotid artery. To reduce the risk of stroke, patients should be evaluated for possible carotid endarterectomy (CEA), which is based on simple geometrical and clinical measures. Multiple studies have shown that the current risk stratification may lead to both over- and under-treatment for patients with carotid artery stenosis. This implicates that the current guidelines are lacking patient-specific parameters and have limited sensitivity. There is a wealth of evidence implicating the important role of local (disturbed) blood flow throughout the onset and progression of atherosclerosis. Novel flow-related measures, that go beyond simple geometrical indications, are required to improve diagnosis and treatment in patients with carotid artery stenosis. Nowadays, ultrasound (US) is one of the main techniques to assess for the presence and extent of carotid artery stenosis. However, current clinically-used US systems are unable to acquire and visualize the complex flow phenomena that play such a crucial role in the atherosclerotic disease process. With the advent of ultrafast ultrasound imaging, acquiring thousands of images per second, continuous tracking of flow in all directions became feasible, which enables us to image two-dimensional blood flow and possible disturbances with high accuracy and precision. In this project, we aim to assess whether flow (related) parameters are associated with disease progression (and if so, which), in order to map the progression of atherosclerotic plaques using non-invasive, US-based blood flow imaging. In the future, this could improve risk stratification for individual patients for surgery, decrease patient mortality and morbidity, and therefore reduce healthcare costs. Objective: To longitudinally assess the association between spatio-temporal blood flow velocities (peak systole and end-diastole at common carotid artery, maximum stenosis and internal carotid artery) and the progression of carotid atherosclerosis defined by duplex measurements. Secondary objectives are to investigate the association between blood flow-derived parameters, including wall shear stress (WSS), vector complexity and vorticity, and the progression of atherosclerosis defined by duplex measurements. Furthermore, to assess the association between spatio-temporal blood flow velocities and blood flow-derived parameters (WSS, vector complexity and vorticity) and the progression of atherosclerosis as measured using ultrasound-based strain imaging.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Apr 2022

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Apr 2022Dec 2026

First Submitted

Initial submission to the registry

February 2, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 8, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

April 7, 2022

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

4.4 years

First QC Date

February 2, 2022

Last Update Submit

February 10, 2025

Conditions

Keywords

Ultrafast ultrasound flow imagingAtherosclerotic plaqueDisease progressionVelocity vector imaging

Outcome Measures

Primary Outcomes (2)

  • Two-dimensional spatio-temporal blood flow velocities

    Two-dimensional vector velocity fields derived from the US-based flow imaging will be used to calculate the spatio-temporal blood flow velocities.

    2 year follow-up

  • Plaque progression (stenosis degree)

    Plaque progression, defined by increase in stenosis degree. Stenosis degree will be quantified by conventional ultrasound imaging.

    2 year follow-up

Secondary Outcomes (5)

  • Wall shear stress

    2 year follow-up

  • Vorticity

    2 year follow-up

  • Vector complexity

    2 year follow-up

  • Plaque progression (deformation)

    2 year follow-up

  • Symptomatic carotid stenosis

    2 year follow-up

Study Arms (1)

Asymptomatic carotid artery stenosis

Patients with an asymptomatic carotid artery stenosis, defined by 30% to 69% narrowing of the carotid artery according to conventional duplex measurements in the absence of ipsilateral retinal or cerebral ischemia in the preceding 6 months.

Diagnostic Test: Ultrasound-based flow imagingDiagnostic Test: Ultrasound-based strain imagingDiagnostic Test: Conventional duplex

Interventions

Ultrasound-based flow imaging of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

Asymptomatic carotid artery stenosis

Ultrasound-based strain imaging of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

Asymptomatic carotid artery stenosis
Conventional duplexDIAGNOSTIC_TEST

Conventional duplex measurements of the carotid artery stenosis will be acquired at baseline and two annual follow-up appointments.

Asymptomatic carotid artery stenosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with an asymptomatic carotid artery stenosis, defined by 30% to 69% narrowing of the carotid artery according to conventional duplex measurements in the absence of ipsilateral retinal or cerebral ischemia in the preceding 6 months.

You may qualify if:

  • Adult male or female (≥18 years old);
  • Informed consent form understood and signed, and patient agrees to follow-up visits;
  • Presence of carotid artery stenosis (between 30%-69%) according to conventional duplex measurements (peak-systolic velocity of 125-230 cm/s \[5\] in combination with visible lumen reduction \>30% according to North American Symptomatic Carotid Endarterectomy Trial \[NASCET\] method);
  • Defined asymptomatic with respect to the ipsilateral carotid artery stenosis.

You may not qualify if:

  • History of carotid revascularisation at artery under investigation;
  • Visible near occlusion at asymptomatic stenosis side according to conventional duplex measurements;
  • Life expectancy \< 2 years;
  • Participating in another clinical study, interfering on outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Rijnstate Hospital

Arnhem, Netherlands

Location

Radboud university medical center

Nijmegen, Netherlands

Location

MeSH Terms

Conditions

Carotid StenosisPlaque, AtheroscleroticDisease Progression

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2022

First Posted

March 8, 2022

Study Start

April 7, 2022

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 12, 2025

Record last verified: 2025-02

Locations